Beijing, February 2025 – China’s healthcare sector is at the center of a rigorous anti-corruption campaign launched in 2023 under President Xi Jinping’s leadership. Over 180 hospital leaders have been investigated, revealing widespread malpractice, including profiteering, kickbacks, and the misuse of medical insurance funds.
Authorities have uncovered over ¥1.2 billion ($170 million) in misappropriated funds, with cases implicating prominent administrators like Dr. Zhang Wei of Guangzhou, who allegedly accepted ¥10 million ($1.4 million) in bribes. Pharmaceutical companies have also come under scrutiny, with one Shanghai-based firm accused of illicitly distributing over ¥50 million ($7 million) in kickbacks.
Public opinion largely supports the crackdown, with many hoping it will restore trust in the healthcare system. However, healthcare professionals urge caution to avoid disruptions in critical medical services. Analysts view this as part of a broader push by Xi’s administration to enforce transparency and ethical governance across sectors.
The campaign’s outcome could redefine healthcare governance in China, setting a strong precedent for institutional reform.